Pierre had been taking a brand name drug for years, even after a generic version became available, because the co-pay was the same. However, his employer implemented a generic substitution policy, and Quebec regulations meant he was only reimbursed 66% of the brand name drug's cost instead of his usual co-pay. Over the years, choosing the brand name drug cost Pierre and his plan hundreds of dollars more for the same medication. Now, members like Pierre face a choice as the 66% reimbursement rule is eliminated, and Pierre will only be reimbursed the generic drug's cost even if he takes the brand name. So the question of whether to choose brand or generic no longer arises for Pierre, as the